News

Plus Therapeutics Faces Nasdaq Compliance Challenge Following Delay

Plus Therapeutics Faces Nasdaq Compliance Challenge Following Delay

Plus Therapeutics Confronts Nasdaq Compliance Issue

Recently, Plus Therapeutics, Inc. (Nasdaq: PSTV) announced that it received a notification from Nasdaq concerning a compliance issue. This notification, issued on a specific date, informed the Company of its non-compliance regarding the timely filing of its Quarterly Report on Form 10-Q, which is due for the ending period. This situation arises as Nasdaq mandates all listed companies to submit required financial reports to the U.S. Securities and Exchange Commission (SEC) punctually.

Understanding the Notification

The notification serves as a formal reminder that companies must adhere to specific regulations regarding financial disclosures. It indicates that Plus Therapeutics failed to meet the requirement outlined in Nasdaq Listing Rule 5250(c)(1). Importantly, while this notification raises concerns about compliance, it does not alter the Company’s current listing status on Nasdaq.

Next Steps for Compliance

In response to this notification, Plus Therapeutics is tasked with formulating a plan to recover its compliance status. This plan must be submitted by a given date, after which Nasdaq may grant an extension to allow the Company additional time to rectify its filing status. The possible extension can last up to 180 calendar days.

Company's Commitment to Filing

Plus Therapeutics is actively working to ensure that the Quarterly Report is completed and filed as soon as possible. The Company emphasizes its commitment to returning to a routine filing schedule for its reports throughout the year as it navigates this challenge.

About Plus Therapeutics

Headquartered in Houston, Texas, Plus Therapeutics focuses on developing innovative treatments for challenging cancers that affect the central nervous system. The Company’s approach combines targeted radiotherapeutics with beta radiation and innovative drug delivery methods. Their leading programs currently address severe conditions like leptomeningeal metastases and recurrent glioblastoma, which affect numerous patients.

Moreover, Plus Therapeutics has established a robust supply chain thanks to strategic partnerships facilitating the development, manufacturing, and potential commercialization of its groundbreaking products. Their pipeline reflects a determined effort to enhance clinical outcomes for patients dealing with difficult-to-treat cancers.

Forward-Looking Statements and Trends

As is typical in the biotech sector, Plus Therapeutics has issued a blend of forward-looking statements regarding its plans and projected timelines. Such statements encompass expectations regarding the completion and timely submission of financial reports and compliance plans required by Nasdaq.

These projections could be influenced by various uncertainties including the regulation, market dynamics, and internal operational efficiencies. As the Company navigates through these waters, it remains committed to keeping its stakeholders informed.

Contact Information

Those interested in learning more or seeking more detailed information can reach out directly to Andrew Sims, CFO of Plus Therapeutics, Inc., at 737-255-7194 or via email.

Frequently Asked Questions

What compliance issue did Plus Therapeutics encounter?

Plus Therapeutics received a notification from Nasdaq regarding a delay in filing their Quarterly Report on Form 10-Q.

How is Plus Therapeutics addressing the compliance issue?

The Company is actively working on a compliance plan that must be submitted to Nasdaq, along with their intention to file the necessary reports timely.

Are there any immediate consequences for the Company?

Currently, there are no immediate consequences affecting the listing of Plus Therapeutics on Nasdaq, but timely compliance is crucial to maintain their listing status.

What is the focus of Plus Therapeutics?

Plus Therapeutics is dedicated to developing targeted therapies for challenging cancers, particularly those impacting the central nervous system.

Who can be contacted for more information about Plus Therapeutics?

Prospective inquiries can be directed to Andrew Sims, CFO, at Plus Therapeutics for more information about the company and its current status.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

TWP & Commbi Unveil Exclusive Pony Clog Collaboration

Updated Category News Views 4

A Fusion of Fashion and Functionality Walk down the streets of New York or hustle your way through an airport without worrying about your footwear weighing you down. That's the promise coming from the fresh alliance between TWP and Commbi with their new Pony Clog Collaboration. A blend of high fashion and everyday utility, these clogs aren't just keeping up with the...

Continue Reading
MSP360 Unveils Free Proxmox Backup: A Game Changer?

Updated Category News Views 7

Backing Up: New Paths for Proxmox Users Ever get that feeling of uncovering something truly worth its weight in gold? That's what MSP360 just dropped on us, with their new backup solution for Proxmox that won’t cost you a dime upfront. They're calling it the Community Edition, and it’s not only free, but it comes with all the bells and whistles for protecting those...

Continue Reading
Mutare Sharpens Security for Webex Calls with Precision

Updated Category News Views 4

Control Dialed In: Tailored Call Screening Kicking things up a notch, Mutare is redefining call security by fine-tuning their Voice Security for Webex Calling. Imagine this—custom rules now let organizations shape a security policy down to the very last detail, ensuring unwanted calls don’t slip through the cracks. Wave goodbye to the broad-strokes approach. Precision...

Continue Reading
MasterBrand's 2027 Kitchen Trends: Embrace Warmth

Updated Category News Views 4

Wood Finishes and the Warm Embrace Alright folks, let's cut through the fluff and get to the heart of the matter: wood finishes are making a roaring comeback in 2027 kitchens. And it's not just some passing phase, we're talking a comprehensive shift toward warmer and more natural kitchen designs. MasterBrand, Inc. isn't just throwing darts at a board here. They surveyed a...

Continue Reading
RxWellness Hits Inc. 5000—Four Straight Wins Impress

Updated Category News Views 4

RxWellness Spine & Health Continues to Impress Well, not many companies can boast about snagging a spot on the Inc. 5000 list four years in a row, but here we are with RxWellness Spine & Health doing just that. Sitting pretty at No. 1,230 nationally—and that's no small feat—these folks are making waves in the healthcare industry. Securing the No. 135 spot in...

Continue Reading
Perk's U.S. Expansion: A Bold Move in Spend Control

Updated Category News Views 4

Perk Aims for U.S. Growth: Will It Pay Off? Amidst the cacophony of market chatter, Perk's announcement to bring its spend platform stateside is echoing louder than usual. This move is not just another step in its expansion but rather a leap considering the competition and market needs. In Europe, where they've already captured a chunk of the market with their Travel and...

Continue Reading
G-STAR & Wu-Tang Clan Unleash Denim Fusion

Updated Category News Views 4

Denim and Old-School Beats: A Fresh Partnership Just when you think fashion collaborations have run their course, along comes something worth the buzz. This fall, G-STAR, the edgy Dutch denim frontrunner, and the legendary hip-hop collective of Wu-Tang Clan are shaking up the apparel scene, blending raw denim with raw rap. It's a multi-year collaboration that doesn't slap...

Continue Reading
Alcott HR's Sales Strategy Gets a Boost with New Hire

Updated Category News Views 8

Alcott HR Ramps Up Sales Firepower Now here's something fresh from the world of human resources outsourcing—Alcott HR has grabbed a new ace for their sales team. Eldin Radoncic is the name you'll want to remember, folks, because he's diving headfirst into the Director of Sales seat at this IRS Certified and ESAC Accredited player based out in good old Farmingdale, New...

Continue Reading
Orthopedic Expert Highlighting Midwest Pain Access Gaps

Updated Category News Views 5

Over in the vast sprawl of rolling plains and prairie winds, folks in the Upper Midwest are grappling with an ironic reality. As technological advancements blaze trails, people suffering from vertebrogenic pain are finding themselves up against a wall of limited access to specialized care. We’ve got Dr. James T. Brunz, the man of the hour, one of only about 15 Intracept...

Continue Reading
CSS Revamps Identity, Emphasizing Senior Living Tech

Updated Category News Views 4

CSS Takes a Bold Step with a Fresh Brand Identity Every now and then, you see a company shake off the old coat and put on a polished new one. That's what CSS is doing with its updated brand, staking its claim as a heavyweight tech player in the senior living sector. No small feat, given the challenges stacked against these aging communities—tasked with keeping...

Continue Reading

Top 5 Most Recently Viewed Articles

Investor Action on Replimune Group, Inc. Securities Explained

Updated Category News Views 137

Understanding the Replimune Group, Inc. Securities Lawsuit In recent developments, investors in Replimune Group, Inc. have an important opportunity to participate in a class action securities lawsuit. This lawsuit addresses allegations of misleading statements made by the company, impacting investors during a specific timeframe. Opportunity for Investors The legal firm...

Continue Reading
Quantifind Emerges as the Leading AI Risk Intelligence Provider

Updated Category News Views 280

Quantifind Achieves Top Ranking in Financial Crimes Report In an era where financial crime is rapidly evolving, Quantifind has secured its position as the premier AI Risk Intelligence Provider according to the latest report by Chartis Research. This recognition highlights the company's influential role in financial crime risk intelligence, empowering institutions...

Continue Reading
Bladex Reports Impressive Third Quarter Earnings Surging Profits

Updated Category News Views 233

Bladex Financial Highlights Banco Latinoamericano de Comercio Exterior, S.A. (NYSE: BLX), known as Bladex, recently reported significant financial results for the third quarter and the first nine months of the year. Their net profits reached an impressive $55.0 million or $1.48 per share in 3Q25, showcasing a solid 4% increase compared to the same period last year. For...

Continue Reading
KBR Secures $113 Million Contract to Transform Digital Engineering

Updated Category News Views 81

KBR Lands $113 Million Contract for Digital Engineering Overhaul KBR has recently celebrated a major milestone with the awarding of a task order valued at around $113 million. This project focuses on essential aeronautical systems research, development, testing, and evaluation, primarily for the Air Force Life Cycle Management Center's Mobility Directorate. This new...

Continue Reading
Element79 Gold Corp's Exciting Participation in Investor Conference

Updated Category News Views 91

Element79 Gold Corp to Present at the Metals & Mining Conference Element79 Gold Corp (OTCQB: ELMGF, CSE: ELEM, FSE: 7YS), a committed player in the gold and silver exploration sector, is gearing up to present at an upcoming virtual investor conference. Details of the Presentation During this live event, the CEO and Director, James C. Tworek, will take center stage on July...

Continue Reading